Large-scale purification of active platelet integrin glycoprotein IIb-IIIa.

Protein Expr Purif

Department of Biotechnology, Experimental Station, Bristol-Myers Squibb Pharma Company, Wilmington, DE 19880, USA.

Published: August 2002

Glycoprotein IIb-IIIa is an abundant platelet receptor of the integrin family that plays a primary role in platelet aggregation. It exists on the platelet surface predominantly in a resting or inactive conformation that is converted to an active binding competent conformation upon platelet activation. There is much interest in studying the difference between active and inactive GP IIb-IIIa, developing therapeutic agents targeted towards GP IIb-IIIa and developing diagnostic assays for antibodies that recognize epitopes on GP IIb-IIIa. We present here the development of a large-scale process for purifying active GP IIb-IIIa from human platelets. The procedure results in 25mg batch sizes of high purity and activity. Additionally, the effects of detergent concentration and impurities such as IgG on ELISA assays are examined.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1046-5928(02)00027-xDOI Listing

Publication Analysis

Top Keywords

glycoprotein iib-iiia
8
iib-iiia developing
8
iib-iiia
6
platelet
5
large-scale purification
4
active
4
purification active
4
active platelet
4
platelet integrin
4
integrin glycoprotein
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!